Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 90 | ECE2023 | Next issue

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

Card image cap
ECE 2023 will be held in Istanbul, Turkey from 13-16 May 2023. Istanbul is known for its rich culture, historical sites and dynamic nightlife, and we are excited to come together in this city, and look forward to meeting old friends, making new ones, and sharing science, collaborations and ideas.

Rapid Communications

Rapid Communications 2: Thyroid

ea0090rc2.1 | Rapid Communications 2: Thyroid | ECE2023

Increased risk of Graves’ orbitopathy following Covid-19 vaccination

Muller Ilaria , Consonni Dario , Crivicich Erica , Di Marco Francesco , Curro Nicola , Salvi Mario

Background: Vaccination is a widely adopted measure against the severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2) causing Covid-19 pandemic. Both SARS-CoV-2 infection and Covid-19 vaccines have been associated with several thyroid disorders. We studied the risk of GravesÂ’ orbitopathy (GO) following Covid-19 vaccination.Methods: The study included 98 consecutive patients (71 females and 27 males, mean-age 50 years) attending our tertiary r...

ea0090rc2.2 | Rapid Communications 2: Thyroid | ECE2023

Overtreatment of differentiated thyroid cancer: impact on real world clinical practice of conservative guidelines, as recorded by the Italian Thyroid Cancer Observatory Study

Grani Giorgio , D'Elia Silvia

Background: The incidence of differentiated thyroid cancers is increasing, mainly due to the overdiagnosis of small papillary thyroid cancers (less than 1 cm, previously known as microcarcinomas). There is a broad consensus in reducing the surgery extent and the use of radioiodine treatment in low-risk cases by most recent clinical practice guidelines focusing on thyroid cancer treatment. The adoption in real clinical practice is usually slow. The aim of this study is to estim...

ea0090rc2.3 | Rapid Communications 2: Thyroid | ECE2023

A simplified four-tier classification of thyroid core needle biopsies (CNB) is an efficient system. Evidence based on more than 1,000 surgical cases

Paja Fano Miguel , Zabala Rosa , Korta Igone , Delgado Sandra , Luis Del Cura Jose , Rodriguez-Soto Josune , Izquierdo Jon , Garai Jon , Oleaga Amelia , Teresa Gutierrez M. , Exposito Amaia , Zufiaurre Maite , Ugalde Aitziber

CNB is increasingly being used as a diagnostic test for thyroid nodules with an inadequate (Bethesda 1) or indeterminate (Bethesda 3 and 4) FNAC results, which can account for up to 30% of the samples in some studies. CNB, using larger specimens and histological sections rather than cytological samples, allows better definition. We propose a simplified four-tiered classification of CNB specimens instead of the Bethesda system and evaluate its efficiency compared to definitive ...

ea0090rc2.4 | Rapid Communications 2: Thyroid | ECE2023

Cell free DNA Integrity index to differentiate benign from malignant thyroid nodules

Tarafdar Soham , Dutta Susmita , P. Bhattacharyya Nitai , Mukhopadhyay Pradip , Ghosh Sujoy

Introduction: Cell-free DNA (cfDNA) integrity in plasma has been investigated as a non-invasive marker in cancer. Thyroid cancer the most common endocrine malignancy sometimes presents as indeterminate nodules and difficult to diagnose without histopathology.Aim of the study: The present study aims to test the hypothesis that the presence of longer DNA strands circulating in plasma can be considered a marker for thyroid cancer.Meth...

ea0090rc2.5 | Rapid Communications 2: Thyroid | ECE2023

Lack of GPER-TSHR heteromers is a hallmark of thyroid cancer

Perri Carmela , D'Alessandro Sara , Paradiso Elia , Lazzaretti Clara , Mascolo Elisa , Baschieri Lara , Roy Neena , Sperduti Samantha , Simoni Manuela , Brigante Giulia , Casarini Livio

Thyroid cancer is the most common type of endocrine tumor and reaches the peak of incidence between the age of twenty and fifty years. It has 4-fold higher prevalence in females than males, suggesting that estrogens and their receptors could be involved in thyroid cancer pathogenesis. Previous studies demonstrated allosteric interference operated by G protein-coupled estrogen receptor (GPER) to molecules structurally similar to the thyroid-stimulating hormone (TSH) receptor (T...